-

Tilray to Report Fourth Quarter and Full Fiscal Year 2019 Financial Results on March 2, 2020

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December 31, 2019 on Monday, March 2, 2020 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. A telephone replay will be available approximately two hours after the call concludes through Monday, March 16, 2020, by dialing 855-859-2056 from the U.S., or 404-537-3406 from international locations, and entering confirmation code 8197352.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.

About Tilray®

Tilray (Nasdaq: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

Contacts

For further information:
Media, Global: Chrissy Roebuck, +1-833-206-8161, news@tilray.com
Investors: Rachel Perkins, +1-646-277-1221, rachel.perkins@icrinc.com

Industry:

Tilray Inc.

NASDAQ:TLRY
Release Versions
English

Contacts

For further information:
Media, Global: Chrissy Roebuck, +1-833-206-8161, news@tilray.com
Investors: Rachel Perkins, +1-646-277-1221, rachel.perkins@icrinc.com

More News From Tilray Inc.

Tilray Expands Medical Cannabis Footprint in Europe

NEW YORK--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in medical cannabis research, cultivation, production, and distribution, today announced it has been selected by the Luxembourg Ministry of Health as a supplier of Good Manufacturing Practice (GMP) certified medical cannabis products for the country’s medical cannabis program. Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts an...

Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada

NEW YORK & TORONTO--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (Nasdaq:TLRY; TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company and Great North Distributors, Inc. (Great North), Canada’s first national sales broker for legalized adult-use cannabis — today announced a signed national brokerage agreement with Tilray Canada Ltd. Under the agreement, Great North will be the exclusive representative for Tilray’s complete portfolio of adult-use cannabis products across t...

Tilray Strengthens Leadership Position in Canada

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announces the expansion of its leadership team with the appointment of Blair MacNeil as President, Tilray Canada. In his new role, Blair will drive Tilray’s next stage of growth in Canada and oversee sales, marketing, and operations across medical and adult-use cannabis businesses. Blair will report to Jim Meiers, who has been appointed to Chief Operations Officer, Tilray, Inc. Ir...
Back to Newsroom